z-logo
open-access-imgOpen Access
DNA methylation episignature testing improves molecular diagnosis of Mendelian chromatinopathies
Author(s) -
Jennifer Kerkhof,
Gabriella Maria Squeo,
Haley McConkey,
Michael A. Levy,
Maria Rosaria Piemontese,
Marco Castori,
Maria Accadia,
Elisa Biamino,
Matteo Della Monica,
Marilena Carmela Di Giacomo,
Cristina Gervasini,
Silvia Maitz,
Daniela Melis,
Donatella Milani,
Maria Piccione,
Paolo Prontera,
Angelo Selicorni,
Bekim Sadiković,
Giuseppe Merla
Publication year - 2021
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1016/j.gim.2021.08.007
Subject(s) - dna methylation , genetics , methylation , biology , computational biology , dna sequencing , dna , bioinformatics , gene , gene expression
Chromatinopathies include more than 50 disorders caused by disease-causing variants of various components of chromatin structure and function. Many of these disorders exhibit unique genome-wide DNA methylation profiles, known as episignatures. In this study, the methylation profile of a large cohort of individuals with chromatinopathies was analyzed for episignature detection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom